It does not prescribe, assess or diagnose
RVer AI ranks the library and shows the evidence behind each suggestion. The choice is always the team's.
The question any service asks before buying. Answered on its own page, not in small print at the end of another one.
The Class I medical device registration (Infarmed, MDR 2017/745) covers the base product: the video library. The modules are complements in development and are not covered. The base product bears the CE mark under MDR 2017/745, self-declared by the manufacturer with no notified body.
Status as of 23/09/2026
Worth writing out in full, rather than inferring it from what goes unsaid.
RVer AI ranks the library and shows the evidence behind each suggestion. The choice is always the team's.
It is a non-pharmacological complement, used under the supervision of the healthcare team.
The intended users are healthcare professionals and trained carers. The patient is always supervised.
No personal or clinical data leaves the headset. Only per-device usage statistics, which identify no one.
Usable in NHS and private hospitals, clinics and health centres across Portugal, under team supervision.
Complies with technical documentation, risk assessment and European standards (MDR 2017/745).
No personal or clinical patient data leaves the headset. Only per-device usage statistics, identifying no one, to improve the app (GDPR).
Medical device registration in Portugal under MDR 2017/745, with the manufacturer established in the European Union. The base product bears the CE mark under MDR 2017/745, self-declared, with no notified body.
We collect published research on virtual reality in healthcare settings. Most of it comes from independent teams; our own team also publishes, and those texts are marked as such.
Most are by independent, peer-reviewed authors; the texts marked as RVer Study are written by our team. None of them is a performance claim for the product, nor a substitute for clinical assessment. The Class I medical device registration (Infarmed) covers the base product.
Caution or prior clinical assessment in: severe motion sickness or vestibular disorders; uncontrolled epilepsy or photosensitive seizures; inability to follow safety instructions.
Healthcare professionals and trained carers, in health or social-care settings. The user is always supervised. Not for self-administration.
Report any serious incident to the manufacturer ([email protected]) and to Infarmed, I.P.
For technical documentation, risk assessment or compliance questions.